Further investigations demonstrated the clinical significance and biological function of TPM3P9 in clear cell renal cell carcinoma (ccRCC), revealing that TPM3P9 promotes tumor growth by enhancing the alternative splicing of oncogenic RNAs. Here, TPM3P9 is linked to clear cell renal carcinoma.